Development Doctors Radiology Regulation 
pharmaphorum
JUNE 3, 2021
The FDA has approved a digital device developed by Cognoa that can be used to diagnose autism spectrum disorder (ASD), just a few weeks after it was filed for approval. Instead, doctors have to look at a child’s developmental history and behaviour over time before making a diagnosis.
pharmaphorum
FEBRUARY 3, 2021
France’s SurgAR has joined with imaging data firm Medexprim to form a three-year partnership with a major hospital in France, to develop augmented reality (AR) software dedicated to laporoscopic surgery. The information comes from preoperative radiological imaging data and aims to guide the surgeon during operations, increasing precision.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 11, 2022
It can mean everything from patient-facing disease management apps and wearables to background AI dramatically altering drug discovery or radiological imaging. As we develop these technologies, it’s not only that we must focus on the patient experience; we need to start with the patient experience,” Hadjiat tells pharmaphorum.
Drug Discovery World
APRIL 14, 2023
He is being recognised for his revolutionary contributions to developing the first gene-edited cell-based therapy for cancer that involves the genetic re-engineering of a patient’s own T cells to combat their disease, and for demonstrating that adoptive T-cell therapy can induce remission and in some cases cure patients with advanced cancer.
pharmaphorum
JUNE 18, 2021
Teasing out complex relationships within data lies at the heart of any digital health intervention, but finding the algorithms to do so reliably – and making sure they will be acceptable to regulators – can be a challenge. The algorithms used in healthcare are becoming more complex as well.
The Pharma Data
NOVEMBER 17, 2020
doctor’s offices, hospitals, urgent care centers and emergency rooms) for all ages but samples must be collected by a healthcare provider when the test is used at the POC to test individuals younger than 14 years old. director of FDA’s Center for Devices and Radiological Health. . .
pharmaphorum
MARCH 16, 2021
We can use the content of the EHRs via artificial intelligence which benefits doctors’ time, and their ability to do research. I started talking about it with other doctors and thought ‘What if we applied some sort of computational linguistics?’ The technology is being embraced by doctors around the world according to Medrano.
Expert insights. Personalized for you.
114 
Let's personalize your content